1. Home
  2. GDL vs NSPR Comparison

GDL vs NSPR Comparison

Compare GDL & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDL
  • NSPR
  • Stock Information
  • Founded
  • GDL 2006
  • NSPR 2005
  • Country
  • GDL United States
  • NSPR United States
  • Employees
  • GDL N/A
  • NSPR N/A
  • Industry
  • GDL Investment Managers
  • NSPR Medical/Dental Instruments
  • Sector
  • GDL Finance
  • NSPR Health Care
  • Exchange
  • GDL Nasdaq
  • NSPR Nasdaq
  • Market Cap
  • GDL 93.3M
  • NSPR 74.8M
  • IPO Year
  • GDL N/A
  • NSPR N/A
  • Fundamental
  • Price
  • GDL $8.45
  • NSPR $2.38
  • Analyst Decision
  • GDL
  • NSPR Strong Buy
  • Analyst Count
  • GDL 0
  • NSPR 2
  • Target Price
  • GDL N/A
  • NSPR $4.50
  • AVG Volume (30 Days)
  • GDL 11.2K
  • NSPR 112.3K
  • Earning Date
  • GDL 01-01-0001
  • NSPR 08-05-2025
  • Dividend Yield
  • GDL 6.02%
  • NSPR N/A
  • EPS Growth
  • GDL N/A
  • NSPR N/A
  • EPS
  • GDL N/A
  • NSPR N/A
  • Revenue
  • GDL N/A
  • NSPR $7,066,000.00
  • Revenue This Year
  • GDL N/A
  • NSPR $4.85
  • Revenue Next Year
  • GDL N/A
  • NSPR $113.47
  • P/E Ratio
  • GDL N/A
  • NSPR N/A
  • Revenue Growth
  • GDL N/A
  • NSPR 7.60
  • 52 Week Low
  • GDL $7.65
  • NSPR $1.99
  • 52 Week High
  • GDL $8.13
  • NSPR $3.80
  • Technical
  • Relative Strength Index (RSI)
  • GDL 58.71
  • NSPR 44.93
  • Support Level
  • GDL $8.35
  • NSPR $2.35
  • Resistance Level
  • GDL $8.50
  • NSPR $2.52
  • Average True Range (ATR)
  • GDL 0.06
  • NSPR 0.14
  • MACD
  • GDL 0.01
  • NSPR -0.02
  • Stochastic Oscillator
  • GDL 78.85
  • NSPR 7.50

About GDL GDL Fund The of Beneficial Interest

GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: